Healthcare - Biotechnology - NASDAQ - US
$ 0.5315
-8.41 %
$ 31.4 M
Market Cap
-0.71
P/E
CASH FLOW STATEMENT
-56.2 M
OPERATING CASH FLOW
11.5 M
INVESTING CASH FLOW
48 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Elevation Oncology, Inc.
| Net Income | -45.7 M |
| Depreciation & Amortization | 39 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 3.34 M |
| Change in Working Capital | -13.7 M |
| Others | -8 M |
| Free Cash Flow | -56.2 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (45.7) | (95.1) | (32.0) | (17.3) | (5.9) |
| Depreciation & Amortization | 39 K | 27 K | 18 K | 15 K | 0 |
| Deferred Income Tax | 0 | 0 | (1.6) | 5.1 | 0 |
| Stock Based Compensation | 3.3 | 3.2 | 1.6 | 52 K | 13.5 K |
| Other Operating Activities | (0.2) | 74 K | 1.6 | (5.1) | (0.5) |
| Change in Working Capital | (13.7) | 6.3 | 0.3 | 4.9 | 0.4 |
| Cash From Operations | (56.2) | (85.5) | (30.2) | (12.3) | (5.5) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | 0 | 86 K | 0 | 71 K | 0 |
| Other Items | 11.5 | (44.3) | 0 | 0 | 0 |
| Cash From Investing Activities | 11.5 | (44.4) | 0 | 71 K | 0 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 24 K | 35 K | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 30.0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.5 | (0.5) | 11 K | 90.0 | 10.8 |
| Cash From Financing Activities | 48.0 | 29.5 | 97.1 | 90.0 | 7.2 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 3.3 | (100.4) | 66.9 | 77.7 | 1.7 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (56.2) | (85.6) | (30.2) | (12.4) | (5.5) |